Things Halvorson said….
In his remarks to (video, no transcript yet) The Commonwealth Club as interviewed by Chris Rauber, who was being rather too nice—although that’s mostly the fault of the stupid written Q&A format the Commonwealth Club uses (You’d think that something vaguely modeled on the UK system would grok the concept of a follow-up question), KP CEO George Halvorson said a few interesting things:
“One of the things we need in American health care is an extremely high level of transparency” (more on that later George!)
“Any time you get to a pure single payer system you get a health care system that rations <snip> if you want a good look at single payer look at the medical systems in our prisons.” I agree with him in his specifics about transparency and how it would be better to have a system with providers competing properly with better information, but with that type of rhetoric is his next job at NCPA or at PRI? C’mon George! Every health care system rations—something John Goodman is actually right about. The question is, how is it done? Just accusing single payer systems of rationing and actually bringing up the erroneous bogeyman of Canadian patients crossing the border puts Halvorson in a camp of wingnuts with whom he ought not to be associating himself.
And as for that transplant program. “It was an excellent program” but on the administration of the list “we just screwed up.” Methinks that David Merlin, the fired administrator of that program and the source of the LA Times story does not agree. Here’s what he said in response in a letter to the SF Business Times today:
Whistleblower: Kaiser’s kidney ills not tied to CEO’s absenceAs the person who exposed the Kaiser kidney transplant program tragedy to state and federal officials and the media, I¹m certain the majority of Kaiser kidney patients are as insulted as I by George Halvorson¹s attempt to portray KP¹s unwillingness to speak up and/or take responsibility due to his six-week absence. KP¹s transplant program had been in operation over 18 months prior to his hospitalization in April 2006. The massive clinical and administrative failures had been identified by Kaiser senior officials long before this. Around May of 2005, a majority of the 48 northern California Kaiser nephrologists (kidney specialists) called an emergency meeting of senior KP physicians (including Robbie Pearl, M.D., CEO of the 6,000 member TPMG physician group) and demanded the fledgling Kaiser kidney program be shut down due to overwhelming concerns of patient neglect and associated health issues and that all 2000-plus patients be sent back to UCSF and UC-Davis Medical Centers.These problems didn’t suddenly surface at the time Halvorson became ill. His comment that the kidney crisis was kept from him during his six-week recuperation rings hollow and his assertion that United Network for Organ Sharing thought Kaiser was transferring one patient, and not 2,000, is both ridiculous and irrelevant. Kaiser (TPMG) doctors were responsible for the day-to-day care of these patients, not UNOS.Kaiser has attempted to portray their internal problems as administrative issues, but as an experienced health-care administrator who personally witnessed the internal operations, I can tell you with certainty the problems stemmed from clinical issues due to inadequate staffing of properly trained physicians and nurses and the personal in-fighting between Kaiser transplant surgeons and transplant nephrologists.Kaiser violated the covenant of public trust between patients and physicians. Thousands of real people endured unnecessary pain and others suffered unnecessary death. In health care, the unnecessary death of a patient is the strongest indicator of quality of care or in Kaiser’s case, lack of care. It doesn’t get any more clinical than that.David MerlinFormer director, Kaiser Kidney Transplant Program San Francisco
It’s worth saying again that the crux of this whole thing is not only was there a screw-up of huge proportions on the UNOS-Kaiser hand-off, but there is the strong suspicion–highlighted by what Merlin says and intensified by Halvorson boasting about the successful outcomes of the transplants that were done–that the KP surgeons were cherry-picking their cases and leaving the marginal ones on the waiting list (if indeed they ever got onto the "new" waiting list). If the meeting between the nephrologists and the senior Permanente staff Merlin talks about took place, you can bet that that was at least one topic of conversation.
Any consummation of their elimination pairings runs afoul of some major impediments.1. GSK + AZ. No way, Jose. GSK’s biggest product is Advair and AZ is hoping Symbicort will be its second biggest. A combination would have to axe one of the two.2. Sanofi-Aventis + Novartis. Not in this century. S-A is France’s stake in the ground for a presence in Pharma while Daniel Vasella and his director allies at Novartis are devout Swiss nationalists. More likely the US of A and France would merge to form one country.3. Merck + S-P. Makes sense in that Fred Hassan admits S-P needs pipeline and while S-P can bring marketing acumen to Merck, try getting the latter to admit they need that.4. Pfizer + Amgen. Amgen’s stock is down now because of their shenanigans on Aranesp, but as of 12/31 their market cap was just under $80 billion. Pfizer didn’t do so well with its last megabuy when they acquired Pharmacia for around $60B. I think Pfizer’s CEO Kindler and CFO Shedlarz would be out on their asses if they tried this. Besides, Amgen chairman-CEO Kevin Sharer is the new president of Big Pharma’s lobbying group, PhRMA, and he wouldn’t sell his own company while he’s serving as the industry’s figurehead spokesman.